GYKI52466 |
NIH Swiss mice |
protective against seizures in maximal electroshock seizure test |
[56] |
|
mouse |
inhibition of seizure activity and recurrence in kainic acid-induced status epilepticus |
[88] |
Telampanel |
rat |
protective activity in the kainate-induced neonatal status epilepticus model |
[89] |
Topiramate |
human |
approved for the treatment of partial seizures, primarily generalized seizures, and seizures associated with Lennox-Gastaut syndrome |
[90-91] |
|
mouse |
protection against seizures induced by infusion of ATPA |
[98] |
|
human |
reduces seizures when administered as an add-on treatment for drug-resistant focal epilepsy |
[101] |
Perampanel |
human |
approved for the treatment of focal epilepsy and generalized tonic-clonic epilepsy; restrains myoclonic or absence seizures |
[102-109] |
|
mouse |
protection against PTZ-induced clonic seizures and psychomotor seizures in the 6-Hz stimulation protocol |
[110] |
|
rat amygdala kindling model |
shortens after-discharge activity and prolongs latency to onset of generalized seizures |
[111, 112] |
|
rat |
block of pilocarpine-induced status epilepticus |
[113] |
|
human |
good efficacy and tolerability in young children with intractable epilepsy |
[116] |